Literature DB >> 34336136

Measles, mumps, and rubella (MMR) vaccine and COVID-19: a systematic review.

Moslem Taheri Soodejani1, Moslem Basti1, Seyyed Mohammad Tabatabaei2, Kourosh Rajabkhah3.   

Abstract

This study was performed to investigate published literature about the association between measles, mumps, and rubella (MMR) vaccine and COVID-19. This is a systematic review in which the databases of Chocrane, Pubmed, Scopus, Web of Science as well as reliable journals including Lancet, New England Journal of Medicine, Jama and also Centers for Disease Control and Prevention (CDC) publications were searched.Out of 169 documents discovered during the literature review, 56 ones were somehow related to the association between MMR vaccine and COVID-19, of which 11 ones mentioned the association between these two, and 8 of them contained a hypothesis about this relationship. A quasi-trial study reported the positive effect of the MMR vaccine on reducing the severity of COVID-19 symptoms among those who received it. Also, a cross-sectional study showed an association between the level of Immunoglobulin G (IgG) mumps and COVID-19. Moreover, a genomic data analysis study also reported the effect of Rubella Immunoglobulin G (IgG) level on COVID-19. It seems that due to the similarity of respiratory diseases including measles, rubella, and mumps to COVID-19, MMR vaccine should be investigated more deeply to see if it is effective in order to deal with this novel disease. IJMEG
Copyright © 2021.

Entities:  

Keywords:  MMR vaccine; SARS cov 2; immunization

Year:  2021        PMID: 34336136      PMCID: PMC8310886     

Source DB:  PubMed          Journal:  Int J Mol Epidemiol Genet        ISSN: 1948-1756


  19 in total

1.  Study design VI - Ecological studies.

Authors:  Kate Ann Levin
Journal:  Evid Based Dent       Date:  2006

2.  Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course.

Authors:  Désirée E Larenas-Linnemann; Fernanda Rodríguez-Monroy
Journal:  Allergy       Date:  2020-09-29       Impact factor: 13.146

3.  Vaccine repurposing approach for preventing COVID 19: can MMR vaccines reduce morbidity and mortality?

Authors:  Anand Anbarasu; Sudha Ramaiah; Paul Livingstone
Journal:  Hum Vaccin Immunother       Date:  2020-06-05       Impact factor: 3.452

4.  Does Early Childhood Vaccination Protect Against COVID-19?

Authors:  Karzan R Sidiq; Dana Khdr Sabir; Shakhawan M Ali; Rimantas Kodzius
Journal:  Front Mol Biosci       Date:  2020-06-05

Review 5.  COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates.

Authors:  Malik Sallam
Journal:  Vaccines (Basel)       Date:  2021-02-16

6.  Relationship between MMR vaccination and severity of Covid-19 infection. Survey among primary care physicians.

Authors:  Inmaculada López-Martin; Eva Andrés Esteban; Francisco Javier García-Martínez
Journal:  Med Clin (Engl Ed)       Date:  2020-12-26

7.  Could an Unrelated Live Attenuated Vaccine Serve as a Preventive Measure To Dampen Septic Inflammation Associated with COVID-19 Infection?

Authors:  Paul L Fidel; Mairi C Noverr
Journal:  mBio       Date:  2020-06-19       Impact factor: 7.867

8.  Protective effects of vaccinations and endemic infections on COVID-19: A hypothesis.

Authors:  Ramachandran Meenakshisundaram; Subramanian Senthilkumaran; Ponniah Thirumalaikolundusubramanian
Journal:  Med Hypotheses       Date:  2020-05-26       Impact factor: 1.538

9.  MMR Vaccination: A Potential Strategy to Reduce Severity and Mortality of COVID-19 Illness.

Authors:  J Wesson Ashford; Jeffrey E Gold; MaryJane A Huenergardt; Ronit B A Katz; Susanne E Strand; Joe Bolanos; Christopher J Wheeler; George Perry; Carr J Smith; Lawrence Steinman; Mike Y Chen; Jeffrey C Wang; Clinton B Ashford; Walton T Roth; Jauhtai Joseph Cheng; Steven Chao; Jennifer Jennings; Daniel Sipple; Vicky Yamamoto; Babak Kateb; David L Earnest
Journal:  Am J Med       Date:  2020-10-23       Impact factor: 4.965

View more
  3 in total

1.  SARS-CoV-2 spike protein displays sequence similarities with paramyxovirus surface proteins; a bioinformatics study.

Authors:  Ehsan Ahmadi; Mohammad Reza Zabihi; Ramin Hosseinzadeh; Leila Mohamed Khosroshahi; Farshid Noorbakhsh
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

2.  Clearance of recalcitrant verruca plana following COVID-19 vaccination.

Authors:  Alpana Mohta
Journal:  JAAD Int       Date:  2022-03-16

3.  A highly efficacious live attenuated mumps virus-based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike.

Authors:  Yuexiu Zhang; Mijia Lu; K C Mahesh; Eunsoo Kim; Mohamed M Shamseldin; Chengjin Ye; Piyush Dravid; Michelle Chamblee; Jun-Gyu Park; Jesse M Hall; Sheetal Trivedi; Supranee Chaiwatpongsakorn; Adam D Kenny; Satyapramod Srinivasa Murthy; Himanshu Sharma; Xueya Liang; Jacob S Yount; Amit Kapoor; Luis Martinez-Sobrido; Purnima Dubey; Prosper N Boyaka; Mark E Peeples; Jianrong Li
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-27       Impact factor: 12.779

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.